Bosentan for pulmonary hypertension secondary to idiopathic pulmonary fibrosis

Bosentan for pulmonary hypertension secondary to idiopathic pulmonary fibrosis

Pulmonary hypertension is a poor prognostic factor in patients with interstitial lung disease. No established treatment exists for pulmonary hypertension secondary to interstitial pneumonia. We describe the case of an 81-year-old woman with idiopathic pulmonary fibrosis (IPF), who was admitted to ou...

Full description

Bibliographic Details
Main Authors: Naomi Onda, Yosuke Tanaka, Mitsunori Hino, Akihiko Gemma
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Bosentan
Endothelin antagonist
Idiopathic pulmonary fibrosis
Pulmonary hypertension
Respiratory failure
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007114000586

Internet

http://www.sciencedirect.com/science/article/pii/S2213007114000586

Similar Items